Liste des communications :
First session :
-
Osteoporosis : Guidelines UpToDate. Tabti → [Communication]
-
Patients treated with zoledronic acid « n=14 ». Negadi et al. → [Communication]
-
Patients treated with Teriparatide « n=18 ». Aldaffari et al. → [Communication]
-
Rheumatoid Arthritis : therapeutic management. Sendani → [Communication]
-
Patients with conventional synthetics DMARDs « n=59». S. Benabadji et al. → [Communication]
-
Patients treated with Methotrexate « n=84 ». S. Tahir et al. → [Communication]
-
Pulmonary involvement in Rheumatoid Arthritis « n=26 ». A.I. Dib et al. → [Communication]
-
Spondylarthritis : UpToDate. Bouabdellah → [Communication]
-
Our series of patients with spondylarthritis « n= 39 ». M. Maasri et al. → [Communication]
Second session :
-
Inflammatory myopathy: UpToDate .K. Bensefia → [Communication]
-
Our series of patients with inflammatory myopathy « 23 cas ». Z. Rais et al. → [Communication]
-
Systemic lupus erythematosus : Treatment UpToDate . Bensaoula et al. → [Communication]
-
Our experience about 143 cases with SLE.H. Bestaoui et al. → [Communication]
Third session :
-
BP targets in diabetics by home BP monitoring « n=208 ». Benmekki et al. → [Communication]
-
Left hypertrophy ventricular in new type 2 diabetes « n=201 ». Benabadji et al. → [Communication]
-
Screening peripheral artery disease in type 2 diabetes « n=234 ». Zini et al. → [Communication]
-
Diabetic peripheral neuropayhy « n=267 ». Zaibek et al. → [Communication]
Fourth session :
-
Requirement doses of insulin to negate acetonuria (n=79). Ghennou → [Communication]
-
Depression in new diabetics « n=244 ». Tahir et al. → [Communication]
-
Statin-Induced Rhabdomyolysis« n=4 ». Sabri et al. → [Communication]
Fivth session :
-
Insulino résistance and inflammatory disease « n=68 ». Aldaffari et al. → [Communication]
-
Adult Still's disease : UpToDate. Cherif Benmoussa → [Communication]
-
Our serie of patients with Still disease « n=4 ». Tchenar et al. → [Communication]
-
Patients treated with biologic DMARDs « n=68 ». K. Belmimoune et al. → [Communication]
-
Insulino resistance and risk of diseases. Lounici → [Communication]
Sanofi Symposia « Meet the needs in diabetes management” A. Lounici → [Communication]